These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8996145)

  • 1. Compliance with practice guidelines for node-negative breast cancer.
    Olivotto A; Coldman AJ; Hislop TG; Trevisan CH; Kula J; Goel V; Sawka C
    J Clin Oncol; 1997 Jan; 15(1):216-22. PubMed ID: 8996145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. British Columbia/Ontario Working Group.
    Sawka C; Olivotto I; Coldman A; Goel V; Holowaty E; Hislop TG
    Br J Cancer; 1997; 75(10):1534-42. PubMed ID: 9166950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).
    Levine M;
    CMAJ; 2001 Jan; 164(2):213. PubMed ID: 11332317
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.
    Verma S; Jackisch C
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):277-86. PubMed ID: 21342045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
    ; Colleoni M; Gelber S; Goldhirsch A; Aebi S; Castiglione-Gertsch M; Price KN; Coates AS; Gelber RD
    J Clin Oncol; 2006 Mar; 24(9):1332-41. PubMed ID: 16505417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
    Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
    Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber RD; Rudenstam CM; Thürlimann B; Price KN; Coates AS; Hürny C; Bernhard J; Lindtner J; Collins J; Senn HJ; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
    J Clin Oncol; 2000 Apr; 18(7):1412-22. PubMed ID: 10735888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for older women with node-positive breast cancer.
    Ginsburg D
    CMAJ; 2001 Sep; 165(5):525, 527. PubMed ID: 11563200
    [No Abstract]   [Full Text] [Related]  

  • 10. Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients.
    Ma AM; Barone J; Wallis AE; Wu NJ; Garcia LB; Estabrook A; Rosenbaum-Smith SM; Tartter PI
    Am J Surg; 2008 Oct; 196(4):500-4. PubMed ID: 18809051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
    Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
    J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer.
    Myrick ME; Schmid SM; Kilic N; Güth U
    Acta Oncol; 2012 Feb; 51(2):247-53. PubMed ID: 21985132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility, compliance and persistence of sequential therapy with aromatase inhibitors following 2-3 years of tamoxifen in endocrine adjuvant breast cancer therapy.
    Kilic N; Myrick ME; Schmid SM; Gueth U
    Oncology; 2011; 81(3-4):151-7. PubMed ID: 22041855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group.
    Holli K; Valavaara R; Blanco G; Kataja V; Hietanen P; Flander M; Pukkala E; Joensuu H
    J Clin Oncol; 2000 Oct; 18(20):3487-94. PubMed ID: 11032589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
    J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.
    Blamey RW; Bates T; Chetty U; Duffy SW; Ellis IO; George D; Mallon E; Mitchell MJ; Monypenny I; Morgan DA; Macmillan RD; Patnick J; Pinder SE
    Eur J Cancer; 2013 Jul; 49(10):2294-302. PubMed ID: 23523089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.
    Palta M; Palta P; Bhavsar NA; Horton JK; Blitzblau RC
    Cancer; 2015 Jan; 121(2):188-93. PubMed ID: 25488523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.